ArticleJournal of clinical laboratory analysis2026
Antibacterial Activity of Fresh and Autoclaved Platelet-Rich Fibrin on Pseudomonas aeruginosa: An In Vitro Study.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePlatelet-rich fibrin (PRF) is widely used in oral and maxillofacial procedures for its regenerative and antimicrobial properties. Structural modifications, such as autoclaving, may enhance its usability. This study compared the antibacterial effects of fresh and autoclaved PRF against Pseudomonas aeruginosa, a clinically relevant nosocomial pathogen.
methodsPRF was prepared from six healthy volunteers. Fresh clots and autoclaved plasma fractions were tested using two centrifugation protocols. Antibacterial activity was assessed by disk diffusion and colony-forming unit (CFU) assays. Methanol extraction evaluated the contribution of heat-stable, non-protein components. Scanning electron microscopy (SEM) analyzed structural changes in PRF membranes following autoclaving.
resultsFresh PRF demonstrated antibacterial activity, with inhibition zones of 13.7 ± 0.6 mm (Protocol A) and 17.3 ± 0.8 mm (Protocol B), and significant CFU reduction. Autoclaved PRF showed slightly larger zones (15.2 ± 0.7 mm and 18.0 ± 0.6 mm) and enhanced efficacy (p < 0.0001), whereas methanol-extracted PRF retained partial activity. SEM revealed a dense fibrin network in fresh PRF and a porous, honeycomb-like architecture in autoclaved PRF, suggesting that structural changes may contribute to improved antibacterial function.
conclusionsBoth fresh and autoclaved PRF exhibited antibacterial activity against P. aeruginosa, with autoclaved PRF showing enhanced efficacy. Activity in methanol-extracted PRF indicates a potential role for heat-stable, non-protein components. These findings highlight thermally treated PRF as a sterilizable, bioactive biomaterial for infection-prone dental and surgical applications. Future studies should identify the specific antibacterial constituents and confirm their efficacy in vivo to support clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.